The Phase 3 trial found Pfizer’s mRNA shot cut flu-like illness by 34.5% compared with a standard flu shot.
  • Mihies@programming.dev
    2·
    4 days ago

    Cool, but then again, it is only so effective. And that even before the godknowwhat mutations. But yes, it certainly seems a step forward.